BiondVax Pharmaceuticals Ltd ADR (NASDAQ:BVXV)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - BVXV

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - BVXV

  • Market Cap$46.150m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS09073Q1058

Company Profile

BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic.BiondVax Pharmaceuticals Ltd is a clinical stage biopharmaceutical company. The company is engaged in developing, manufacturing and commercializing immunomodulation therapies for infectious diseases.

Latest BVXV news

Currently there for this company. Visit our news hub for other news .